Table 1.
Patient characteristics (n = 44)
| Median age (range), years | 47 (23–70) |
|---|---|
| FIGO stage | |
| IB1 (%) | 15 (34.1%) |
| IB2 (%) | 8 (18.2%) |
| IIA1 (%) | 11 (25.0%) |
| IIA2 (%) | 10 (22.7%) |
| Histology | |
| Squamous carcinoma (%) | 40 (90.9%) |
| Adenocarcinoma (%) | 4 (9.1%) |
| Stromal invasion ≥1/2 depth (%) | 31 (70.5%) |
| Lymph node metastasis (%) | 18 (40.9%) |
| Positive lymphvascular invasion (%) | 21 (47.7%) |
| Median follow up (range), months | 41 (2–48) |
| Disease status at last follow-up | |
| Alive, no evidence of disease (%) | 36 (81.8%) |
| Alive, with disease (%) | 5 (11.4%) |
| Dead with disease (%) | 3 (6.8%) |
Abbreviations: FIGO International Federation of Gynecology and Obstetrics